Every other month DMRF Canada publishes Going Forward; our bi-monthly e-newsletter.
What's Making News
We are excited to share with you the 2016 DMRF Canada Annual Report. You can Click here to read more.
In November 2017, an article was published featuring Claire Smith. Our thanks to Clair for helping to raise awareness of dystonia, and sharing her heartfelt story. It is brave individuals like Claire that will help us to make dystonia known to healthcare practitioners and the general public. To see Claire’s story as featured on our site, click here.
Life Impact and Chronic Pain Treatment Perspectives.
Dystonia advocate Tom Seaman’s article is featured in the January 2018 issue of Pain-Free Living Magazine. See the complete article below.
Toronto Western General Hospital is conducting a clinical research study to test a new drug for Cervical Dystonia (abnormal spasms in the neck).
The drug is currently approved for use in the USA and Canada for treating epilepsy. The purpose of this study is to test the safety and benefit in treating the symptoms of cervical dystonia.
All participants receive the active drug.
To participate you must:
CDR recommends Dysport Therapeutic™ be reimbursed for reducing the signs and symptoms of cervical dystonia in adults